Discovery of a potent atrial natriuretic peptide antagonist for ANPA receptors in the human neuroblastoma NB-OK-1 cell line
C Delporte, J Winand, P Poloczek… - European journal of …, 1992 - Elsevier
C Delporte, J Winand, P Poloczek, T Von Geldern, J Christophe
European journal of pharmacology, 1992•ElsevierThe effects of seven competitive atrial natriuretic peptide (ANP) receptor antagonists were
compared on cultured human neuroblastoma NB-OK-1 cells expressing exclusively ANP A
receptors, by evaluating their capacity to inhibit [125 I] ANP binding and to suppress ANP-
stimulated cyclic GMP elevation. In ANP analogues with a shortened Cys 7-Cys 18 bridge,
Asp 13 and a hydrophobic Tic residue at position 16 expressed antagonistic activity, while
Ala 16 provoked lower antagonistic potency and Phe 16 induced receptor activation. The …
compared on cultured human neuroblastoma NB-OK-1 cells expressing exclusively ANP A
receptors, by evaluating their capacity to inhibit [125 I] ANP binding and to suppress ANP-
stimulated cyclic GMP elevation. In ANP analogues with a shortened Cys 7-Cys 18 bridge,
Asp 13 and a hydrophobic Tic residue at position 16 expressed antagonistic activity, while
Ala 16 provoked lower antagonistic potency and Phe 16 induced receptor activation. The …
Abstract
The effects of seven competitive atrial natriuretic peptide (ANP) receptor antagonists were compared on cultured human neuroblastoma NB-OK-1 cells expressing exclusively ANPA receptors, by evaluating their capacity to inhibit [125I]ANP binding and to suppress ANP-stimulated cyclic GMP elevation. In ANP analogues with a shortened Cys7-Cys18 bridge, Asp13 and a hydrophobic Tic residue at position 16 expressed antagonistic activity, while Ala16 provoked lower antagonistic potency and Phe16 induced receptor activation. The binding affinity of A71915 ([Arg6,Chs8]ANP-(6-15)-D-Tic-Arg-Cya-NH2), the most potent antagonist (with a pKi of 9.18 and a pA2 of 9.48) was only 22 times less lower than that of the agonist ANP-(1-28).
Elsevier
